Walmsley’s Dream Hire Badly Needs to Find Some Blockbuster Drugs
NeutralTechnology

Emma Walmsley, CEO of GSK Plc, has long viewed Luke Miels as a key player for her vision at the company. As she approaches nearly nine years in her role, the pressure is on to deliver groundbreaking drugs that can redefine GSK's future. This matters because the pharmaceutical industry is highly competitive, and the success of GSK hinges on innovative developments that can capture market attention and improve patient outcomes.
— Curated by the World Pulse Now AI Editorial System